FDA Drug recall D-1094-2017
Voriconazole Tablets, 200 mg, 20-count cartons (4 x 5) Unit Dose, Rx only, Manufactured for: AvKARE, Inc
- FDA Drug
- Class III
- terminated
- Published 2017-08-23
On 2017-08-23 the FDA classified a Class III recall of Voriconazole Tablets, 200 mg, 20-count cartons (4 x 5) Unit Dose, Rx only, Manufactured for: AvKARE, Inc by Avkare, citing failed impurities/degradation specifications: Out of specification for a related compound C.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-1094-2017 |
| Classification | Class III |
| Status | terminated |
| Initiated | 2017-07-19 |
| Published | 2017-08-23 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Avkare |
| Distribution | US |
Product
Voriconazole Tablets, 200 mg, 20-count cartons (4 x 5) Unit Dose, Rx only, Manufactured for: AvKARE, Inc. Pulaski, TN 38478, NDC 50268-804-12
Reason
Failed impurities/degradation specifications: Out of specification for a related compound C.
Identifiers
| code_info | Lot #: 16933, Exp 07/2018; 17054, Exp 08/2018 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1094-2017%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.